HCMG 215 - Management and Economics of Pharmaceutical,Biotechnology,and Medical Device Industries

Institution:

University of Pennsylvania

Subject:

Description:

Danzon. Prerequisite(s): One undergraduate Health Care course or one Economics course or equivalent experience with permission of instructor. This course provides an overview of the management, economic and policy issues facing the pharmaceutical, biotechnology, and medical device industries. The course perspective is global with emphasis on the U.S. as the largest and most profitable market. Critical issues we will examine include: R&D intensive cost structure and rapid technological change; biotechnology and genomics startups and alliances with the pharma industry; a complex global marketplace in which prices are regulated in most countries and customers include governments and insurers, as well as physicians, pharmacists and consumers now reachable through DTC; intense and evolving M&A, including mergers, joint ventures, and complex alliances; government regulation of every business function: R&D, pricing, manufacturing, and promotion; and global products and multinational firms. We use industry and Wharton experts from various disciplines to address these issues.

Credits:

3.00

Credit Hours:

Prerequisites:

Corequisites:

Exclusions:

Level:

Instructional Type:

Lecture

Notes:

Additional Information:

Historical Version(s):

Institution Website:

www.upenn.edu

Phone Number:

(215) 898-5000

Regional Accreditation:

Middle States Association of Colleges and Schools

Calendar System:

Semester

The Course Profile information is provided and updated by third parties including the respective institutions. While the institutions are able to update their information at any time, the information is not independently validated, and no party associated with this website can accept responsibility for its accuracy.